Study of novel biosynthetic pathway of BH_4 which concern human aldo-keto reductases
人醛酮还原酶BH_4新生物合成途径的研究
基本信息
- 批准号:16591059
- 负责人:
- 金额:$ 2.3万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2004
- 资助国家:日本
- 起止时间:2004 至 2005
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Tetrahydrobiopterin (BH_4) is a cofactor for aromatic amino acid hydroxylases and nitric oxide synthase. The biosynthesis includes two reduction steps catalyzed by sepiapterin reductase.PPH_4 is reduced to 6-(1'-oxo-2'-hydroxypropyl)-tetrahydropterin (1'-OXPH_4) or 6-(1'-hydroxy-2'-oxopropyl)-tetrahydropterin (2'-OXPH_4), which is further converted to BH_4.In 2001, sepiapterin reductase (SPR) deficiency was reported in dystonia like disease. However. patients with SPR deficiency show normal urinary excretion of pterins without hyperphenylalaninemia, suggesting the existence of another BH_4 biosynthetic pathway, which is not concerned with SPR in humans.Recently. we reported a new SPR-unrelated BH_4 formation route from PPH_4, in which human aldo-keto reductase (AKR1C3 and AKR1B1) work in concert.. In the reduction of PPH_4 by AIM family enzymes, 2'-OXPH_4 was formed by 3α-hydroxysteroid dehydrogenase type 2(AKR1C3), whereas 1'-OXPH_4 was produced by aldose reductaseUK.R1B1), respectably.Blau et al. proposed a BH_4 biosynthetic salvage pathway containing nonenzymatic conversion of 1'-OXPH_4 to sepiapterin. In this study, the possibility of the nonenzymatic conversion of 1'-OXPH_4 to sepiapterin was examined by using human aldo-keto reductase(AKR1B1) and human monomeric carbonyl reductase. Since 1'-OXPH_4 has been suggested to be nonenzymatically converted into sepiapterin, in an incubation mixture containing PPH_4 and AKR1B1, sepiapterin was determined by its derivative as biopterin. No sepiapterin was detected in the incubation mixture when the mixture containing 800 pmol of 1'-OXPH_4 was further incubated at 37℃ for 2 h in darkness. This result suggests that the rate of the nonenzymatic formation of sepiapterin from 1'-OXPH_4 is quite low. The findings obtained here indicate that the proposed pathway in which a nonenzymatic conversion of 1'-OXPH_4 to sepiapterin occurs may be difficult or unlikely to proceed in humans.
四氢生物蝶呤(BH_4)是芳香氨基酸羟化酶和一氧化氮合酶的辅助因子。该生物合成包括两个还原步骤,由七叶皂苷还原酶催化。PPH_4还原为6-(1'-氧-2'-羟丙基)-四氢蝶呤(1'- oxph_4)或6-(1'-羟基-2'-氧丙基)-四氢蝶呤(2'- oxph_4),进一步转化为BH_4。2001年,在肌张力障碍样疾病中报道了sepapterin还原酶(SPR)缺乏症。然而。SPR缺乏症患者尿中蝶呤排泄正常,无高苯丙氨酸血症,提示存在另一种与人类SPR无关的BH_4生物合成途径。我们报道了一个与spr无关的PPH_4形成BH_4的新途径,其中人类醛酮还原酶(AKR1C3和AKR1B1)协同工作。AIM家族酶还原PPH_4时,2′-OXPH_4由3α-羟基类固醇脱氢酶2型(AKR1C3)生成,1′-OXPH_4由醛糖还原酶euk生成。R1B1),体面地。Blau等人提出了一种BH_4生物合成回收途径,该途径包含1'-OXPH_4到sepapterin的非酶转化。本研究利用人醛酮还原酶(AKR1B1)和人单体羰基还原酶,考察了1′-OXPH_4非酶转化为七叶黄素的可能性。由于1'-OXPH_4被认为可以非酶转化为sepapterin,在含有PPH_4和AKR1B1的孵育混合物中,sepapterin被确定为生物蝶呤(biopterin)。将含有800 pmol 1′-OXPH_4的培养液在37℃、黑暗条件下孵育2 h后,未检测到sepapterin。这一结果表明,1′-OXPH_4非酶促生成七叶蝶呤的速率很低。本文的研究结果表明,1'-OXPH_4非酶转化为sepapterin的途径可能很难或不太可能在人类中进行。
项目成果
期刊论文数量(20)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Possibility of the Nonenzymatic Conversion of 6-(1'Oxo-2'-hydroxypropyl)-Ttrahydrobiopterin to Sepiapterin
6-(1Oxo-2-羟丙基)-四氢生物蝶呤非酶转化为墨蝶呤的可能性
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Mahler M;Kessenbrock K;Szmyrka M;Takasaki Y;et al.;H.Sawada et al.
- 通讯作者:H.Sawada et al.
Analysis of genes related to expression of aromatase and estradiol-regulated genes during sex differentiation in Xenopus embryos.
- DOI:10.1016/j.ygcen.2004.01.014
- 发表时间:2004-05
- 期刊:
- 影响因子:2.7
- 作者:N. Akatsuka;Hiroshi Kobayashi;E. Watanabe;T. Iino;K. Miyashita;S. Miyata
- 通讯作者:N. Akatsuka;Hiroshi Kobayashi;E. Watanabe;T. Iino;K. Miyashita;S. Miyata
Molecular poprerties and tissue distribution of 30K proteins as ommim-binding proteins from diapause eggs of the silkworm. Bombyx mori
家蚕滞育卵中 30K 蛋白作为 ommim 结合蛋白的分子特征和组织分布。
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Thorburn DR;Sugiana C;Salemi R;Kirby DM;Worgan L;Ohtake A et al.;Kawashima H et al.;大竹 明;T.Makayama et al.;H.Sawada
- 通讯作者:H.Sawada
A novel RNA helicase-like protein during early embryonic development in silkworm Bombyx mori:: Molecular characterization and intracellular localization
- DOI:10.1016/j.ibmb.2006.09.002
- 发表时间:2006-12-01
- 期刊:
- 影响因子:3.8
- 作者:Sawada, H.;Yamahama, Y.;Iino, T.
- 通讯作者:Iino, T.
Possibility of the Nonenzymatic Conversion of 6-(1'-oxo-2'hydroxypropyl)Tetrahydrobiopterin to Sepiapterin
6-(1-氧代-2羟丙基)四氢生物蝶呤非酶转化为墨蝶呤的可能性
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Nakamura M;Kawashima H et.;H.Sawada
- 通讯作者:H.Sawada
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
IINO Teruhiko其他文献
IINO Teruhiko的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('IINO Teruhiko', 18)}}的其他基金
Expression analysis of the aldo-keto reductases involved in the novel biosynthetic pathway of tetrahydrobiopterin in human and mouse tissues
人和小鼠组织中参与四氢生物蝶呤新生物合成途径的醛酮还原酶的表达分析
- 批准号:
18591170 - 财政年份:2006
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The novel biosynthetic pathway of tetrahydrobiopterin
四氢生物蝶呤的新型生物合成途径
- 批准号:
14570776 - 财政年份:2002
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Relationship of atypical phenylketonuria and a new type of carbonyl reductase which related to synthesize BH4
非典型苯丙酮尿症与合成BH4的新型羰基还原酶的关系
- 批准号:
12670785 - 财政年份:2000
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Occurrence of a New Tetrahydrobiopterin Synthesizing enzyme in the human being
人类体内新型四氢生物蝶呤合成酶的出现
- 批准号:
10670765 - 财政年份:1998
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
卵巣明細胞癌に対するCarbonyl reductase 1遺伝子治療の有効性
羰基还原酶1基因治疗卵巢透明细胞癌的疗效
- 批准号:
22K16848 - 财政年份:2022
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Therapeutic strategy of advanced ovarian cancer by targeting carbonyl reductase 1
以羰基还原酶1为靶点的晚期卵巢癌治疗策略
- 批准号:
20K09589 - 财政年份:2020
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A novel therapeutic method for uterine cervical cancer by Arsenic trioxide via inducing Carbonyl reductase 1
三氧化二砷诱导羰基还原酶1治疗宫颈癌的新方法
- 批准号:
20K18222 - 财政年份:2020
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mechanism of inhibitory effect of Carbonyl reductase on cancers aiming to gene therapy
羰基还原酶对癌症基因治疗的抑制作用机制
- 批准号:
26462508 - 财政年份:2014
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of carbonyl reductase function -development of the new molecular target therapy-
羰基还原酶功能分析-新型分子靶向治疗的开发-
- 批准号:
23592452 - 财政年份:2011
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Carbonyl reductase-based production of enantipure alcohol libraries for use as pharmaceutical building blocks
基于羰基还原酶的对映纯醇库的生产,用作药物构建模块
- 批准号:
130236 - 财政年份:2010
- 资助金额:
$ 2.3万 - 项目类别:
BEIS-Funded Programmes
STRUCT/FUNCT ANALYSIS OF ANTHRACYCLINE REDUCTION BY HUMAN CARBONYL REDUCTASE
人羰基还原酶还原蒽环类化合物的结构/功能分析
- 批准号:
7959934 - 财政年份:2009
- 资助金额:
$ 2.3万 - 项目类别:
STRUCT/FUNCT ANALYSIS OF ANTHRACYCLINE REDUCTION BY HUMAN CARBONYL REDUCTASE
人羰基还原酶还原蒽环类化合物的结构/功能分析
- 批准号:
7720019 - 财政年份:2008
- 资助金额:
$ 2.3万 - 项目类别:
STRUCT/FUNCT ANALYSIS OF ANTHRACYCLINE REDUCTION BY HUMAN CARBONYL REDUCTASE
人羰基还原酶还原蒽环类化合物的结构/功能分析
- 批准号:
7609920 - 财政年份:2007
- 资助金额:
$ 2.3万 - 项目类别:
STRUCT/FUNCT ANALYSIS OF ANTHRACYCLINE REDUCTION BY HUMAN CARBONYL REDUCTASE
人羰基还原酶还原蒽环类化合物的结构/功能分析
- 批准号:
7381311 - 财政年份:2006
- 资助金额:
$ 2.3万 - 项目类别: